Extrahepatic Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Extrahepatic Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract [Phase 2]
Phase 2 trial of Taxoprexin for advanced primary cancers of the liver, gallbladder, or biliary tract was terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer [Phase 2]
This clinical trial update notes the completion of a phase 2 study evaluating nanoliposomal irinotecan (nal-IRI) with either 5-fluorouracil/…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
This clinical trial update reports the termination of a feasibility study evaluating multi-platform profiling of resected biliary tract canc…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)
Expanded Access for ABC294640 (Yeliva) in advanced cholangiocarcinoma has been closed and is no longer available.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 study of irinotecan liposome injection in patients with advanced biliary tract cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]
Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma [Phase 2]
Observational real-world Phase 2 study evaluating toripalimab plus TACE for extrahepatic cholangiocarcinoma.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer [Phase 2]
A Phase 2 clinical trial evaluating adjuvant immunotherapy in combination with chemoradiation for high-risk resectable biliary tract cancers…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers [Phase 3]
Phase 3 trial evaluating early palliative care added to standard care versus standard care alone in patients with incurable lung or non-colo…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma [Phase 2]
This report covers a Phase 2 trial of GEMOX (gemcitabine plus oxaliplatin) for advanced or recurrent extrahepatic cholangiocarcinoma and gal…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder [Phase 2]
Phase 2 trial evaluating Bortezomib in unresectable or metastatic adenocarcinoma of the bile duct or gallbladder was terminated; results wer…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: MRCP Diagnoses EHCC Better When Combined DWI [NA]
A completed clinical trial indicates that using MRCP in combination with diffusion-weighted imaging improves the diagnostic accuracy for ext…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy in unresectable or metastatic biliary tract and gallbladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial of selumetinib in biliary tract cancers, including intrahepatic and extrahepatic cholangiocarcinoma, has completed with result…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating MK-2206 in patients with advanced biliary cancers (including hepatocellular carcinoma and gallbladder/extrahepatic …
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy [Phase 2]
Phase 2 trial evaluating gemcitabine and cisplatin plus sorafenib in advanced biliary tract cancers (extrahepatic cholangiocarcinoma and gal…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating chemoradiation with gemcitabine and continuous 5-FU followed by high-dose brachytherapy/SBRT boost in locally advan…
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial results update on lapatinib for biliary tract and primary liver cancers that are unresectable or unresected; study co…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer [NA]
Clinical trial update on radioactive stents for unresectable biliary tract cancers, including intrahepatic cholangiocarcinoma, extrahepatic …
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer [Phase 2]
Phase 2 trial of dolastatin 10 in metastatic or recurrent liver cancer, extrahepatic bile duct cancer, and gallbladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating the combination of sorafenib and erlotinib in locally advanced, unresectable, or metastatic gallbladder cancer or c…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating sorafenib for unresectable or metastatic gallbladder cancer and cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
This completed clinical trial evaluated whether certain blood proteins could serve as biomarkers for detecting pancreatic cancer and extrahe…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer [Phase 1]
A Phase 1 study evaluating the safety and feasibility of combining oxaliplatin, gemcitabine, erlotinib, and radiation therapy in patients wi…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct [Phase 2]
Phase 2 clinical trial examining chemotherapy for locally advanced or metastatic pancreatic cancer and extrahepatic bile duct cancer; the st…